Order Article Reprints

Chen H-Y, Chiang Y-F, Huang J-S, Huang T-C, Shih Y-H, Wang K-L, Ali M, Hong Y-H, Shieh T-M, Hsia S-M. Isoliquiritigenin Reverses Epithelial-Mesenchymal Transition Through Modulation of the TGF-β/Smad Signaling Pathway in Endometrial Cancer. Cancers. 2021; 13(6):1236. https://doi.org/10.3390/cancers13061236

Chen, Hsin-Yuan, Yi-Fen Chiang, Jia-Syuan Huang, Tsui-Chin Huang, Yin-Hwa Shih, Kai-Lee Wang, Mohamed Ali, Yong-Han Hong, Tzong-Ming Shieh, and Shih-Min Hsia. 2021. "Isoliquiritigenin Reverses Epithelial-Mesenchymal Transition Through Modulation of the TGF-β/Smad Signaling Pathway in Endometrial Cancer" Cancers 13, no. 6: 1236. https://doi.org/10.3390/cancers13061236

Chen, H.-Y., Chiang, Y.-F., Huang, J.-S., Huang, T.-C., Shih, Y.-H., Wang, K.-L., Ali, M., Hong, Y.-H., Shieh, T.-M., & Hsia, S.-M. (2021). Isoliquiritigenin Reverses Epithelial-Mesenchymal Transition Through Modulation of the TGF-β/Smad Signaling Pathway in Endometrial Cancer. Cancers, 13(6), 1236. https://doi.org/10.3390/cancers13061236